Amend the bill by striking out everything after the enacting clause and before the summary and inserting the following:

summary

This amendment is a minority report of the Joint Standing Committee on Judiciary. It replaces the bill, which eliminates the existing exemption for patent infringement claims that include claims for relief under the federal pharmaceutical approval statutes. This amendment narrows the exemption to apply to only good faith demand letters and good faith assertions of patent infringement arising under 35 United States Code, Section 271(e)(2) or 42 United States Code, Section 262.